Cargando…
Agarose Gel: An Overview of the Dermal Filler and a Clinical Experience With 700 Patients
BACKGROUND: Dermal fillers currently in the market have several advantages and disadvantages over each other. Agarose gel (AG) is a unique material due to its special rheological characteristics and gel-forming capability. OBJECTIVES: The authors aimed to share their clinical experience on AG for a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494782/ https://www.ncbi.nlm.nih.gov/pubmed/37700788 http://dx.doi.org/10.1093/asjof/ojad051 |
_version_ | 1785104774889209856 |
---|---|
author | Buhsem, Omer Kirazoglu, Ahmet |
author_facet | Buhsem, Omer Kirazoglu, Ahmet |
author_sort | Buhsem, Omer |
collection | PubMed |
description | BACKGROUND: Dermal fillers currently in the market have several advantages and disadvantages over each other. Agarose gel (AG) is a unique material due to its special rheological characteristics and gel-forming capability. OBJECTIVES: The authors aimed to share their clinical experience on AG for a variety of facial augmentation procedures and its long-term results. METHODS: The study population consisted of 700 patients (532 females; 168 males) aged 18 to 52 years. Follow-up visits were at 1, 3, 6, 12, and 24 months after the injections. Patient satisfaction was evaluated on a scale from 0 to 10 using a survey and clinical improvement was evaluated using the Global Aesthetic Improvement Scale (GAIS) by 2 independent plastic surgeons before the injection and at 1-year follow-up. RESULTS: Eighty-two percent of the patients scored 1 or 2 (exceptional or great improvement) on GAIS. Eighty-five percent of the patients scored 8 or above (very satisfied). Most patients experienced at least 80% persistence of effect at 1-year follow-up. CONCLUSIONS: AG appears to be suitable for a variety of facial augmentation and contouring applications, as it is safe and has long-lasting favorable cosmetic efficacy. LEVEL OF EVIDENCE: 3: [Image: see text] |
format | Online Article Text |
id | pubmed-10494782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104947822023-09-12 Agarose Gel: An Overview of the Dermal Filler and a Clinical Experience With 700 Patients Buhsem, Omer Kirazoglu, Ahmet Aesthet Surg J Open Forum Original Article BACKGROUND: Dermal fillers currently in the market have several advantages and disadvantages over each other. Agarose gel (AG) is a unique material due to its special rheological characteristics and gel-forming capability. OBJECTIVES: The authors aimed to share their clinical experience on AG for a variety of facial augmentation procedures and its long-term results. METHODS: The study population consisted of 700 patients (532 females; 168 males) aged 18 to 52 years. Follow-up visits were at 1, 3, 6, 12, and 24 months after the injections. Patient satisfaction was evaluated on a scale from 0 to 10 using a survey and clinical improvement was evaluated using the Global Aesthetic Improvement Scale (GAIS) by 2 independent plastic surgeons before the injection and at 1-year follow-up. RESULTS: Eighty-two percent of the patients scored 1 or 2 (exceptional or great improvement) on GAIS. Eighty-five percent of the patients scored 8 or above (very satisfied). Most patients experienced at least 80% persistence of effect at 1-year follow-up. CONCLUSIONS: AG appears to be suitable for a variety of facial augmentation and contouring applications, as it is safe and has long-lasting favorable cosmetic efficacy. LEVEL OF EVIDENCE: 3: [Image: see text] Oxford University Press 2023-06-14 /pmc/articles/PMC10494782/ /pubmed/37700788 http://dx.doi.org/10.1093/asjof/ojad051 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of The Aesthetic Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Buhsem, Omer Kirazoglu, Ahmet Agarose Gel: An Overview of the Dermal Filler and a Clinical Experience With 700 Patients |
title | Agarose Gel: An Overview of the Dermal Filler and a Clinical Experience With 700 Patients |
title_full | Agarose Gel: An Overview of the Dermal Filler and a Clinical Experience With 700 Patients |
title_fullStr | Agarose Gel: An Overview of the Dermal Filler and a Clinical Experience With 700 Patients |
title_full_unstemmed | Agarose Gel: An Overview of the Dermal Filler and a Clinical Experience With 700 Patients |
title_short | Agarose Gel: An Overview of the Dermal Filler and a Clinical Experience With 700 Patients |
title_sort | agarose gel: an overview of the dermal filler and a clinical experience with 700 patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494782/ https://www.ncbi.nlm.nih.gov/pubmed/37700788 http://dx.doi.org/10.1093/asjof/ojad051 |
work_keys_str_mv | AT buhsemomer agarosegelanoverviewofthedermalfillerandaclinicalexperiencewith700patients AT kirazogluahmet agarosegelanoverviewofthedermalfillerandaclinicalexperiencewith700patients |